Cematrix Corporation CEO Jeff Kendrick joined Steve Darling from Proactive to share news about the company that manufactures and supplies cellular concrete products developed from proprietary formulations for cement-based material. CEMATRIX's cellulite concrete finds applications in backfilling overpasses, bridge abutments, tunnels, utility installations, and road underlays in unstable or seismic-prone soils. The company does not replace regular concrete but provides a better and cost-effective solution compared to other support materials.
Kendrick telling Proactive the company has seen continued success in business development this year executed 5.9 million dollars in new contracts. The company says they have a backlog in contracts and 38.2 million dollars of the current backlog is scheduled for 2023. 34 million of the 2023 backlog is contracted and a portion of these contracts have already been placed in 2023.